Medical device licence · 105116 · Class 2
YUMIZEN C1200
Yes: licensed in Canada
Licence status Issued (active); first licensed September 3, 2020. It is in Health Canada’s list of active licences.
- Licence number
- 105116
- Licence holder
- Horiba Abx SasMontpellier, France
- Risk class
- Class II (low to moderate risk)
- Licence type
- System
- First licensed
- September 3, 2020
- Devices covered
- 24
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- CL- CHLORIDE ELECTRODE
- K+ POTASSIUM ELECTRODE
- NA+ SODIUM ELECTRODE
- REF. REFERENCE ELECTRODE
- YUMIZEN C1200
- YUMIZEN C1200 ALBUMIN
- YUMIZEN C1200 ALP
- YUMIZEN C1200 ALT
- YUMIZEN C1200 AMYLASE
- YUMIZEN C1200 AST
- YUMIZEN C1200 CHOLESTEROL
- YUMIZEN C1200 CK-NAC
- YUMIZEN C1200 CO2
- YUMIZEN C1200 COMPLEMENT
- YUMIZEN C1200 COMPLEMENT C4
- YUMIZEN C1200 CREATININE JAFFE
- YUMIZEN C1200 DIRECT BILIRUBIN
- YUMIZEN C1200 GGT
- YUMIZEN C1200 GLUCOSE HK
- YUMIZEN C1200 LACTATE
- YUMIZEN C1200 LDH
- YUMIZEN C1200 LIPASE
- YUMIZEN C1200 MAGNESIUM
- YUMIZEN C1200 TOTAL BILIRUBIN
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.